Audentes Therapeutics, Inc. - Net Worth and Insider Trading
Audentes Therapeutics, Inc. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Audentes Therapeutics, Inc. owns 1 companies in total, including Taysha Gene Therapies Inc (TSHA) .
Click here to see the complete history of Audentes Therapeutics, Inc.’s form 4 insider trades.
Insider Ownership Summary of Audentes Therapeutics, Inc.
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
TSHA | Taysha Gene Therapies Inc | 2022-10-21 | 10 percent owner |
Audentes Therapeutics, Inc. Trading Performance
Audentes Therapeutics, Inc. Ownership Network
Audentes Therapeutics, Inc. Owned Company Details
What does Taysha Gene Therapies Inc do?
Who are the key executives at Taysha Gene Therapies Inc?
Audentes Therapeutics, Inc. is the 10 percent owner of Taysha Gene Therapies Inc. Other key executives at Taysha Gene Therapies Inc include director & 10 percent owner Paul B Manning , Chief Financial Officer Kamran Alam , and 10 percent owner Session R.a. Ii .
Taysha Gene Therapies Inc (TSHA) Insider Trades Summary
Over the past 18 months, Audentes Therapeutics, Inc. made no insider transaction in Taysha Gene Therapies Inc (TSHA). Other recent insider transactions involving Taysha Gene Therapies Inc (TSHA) include a net purchase of 17,900,000 shares made by Paul B Manning , a net sale of 549,095 shares made by Session R.a. Ii , and a net purchase of 777,778 shares made by Stalfort John A Iii .
In summary, during the past 3 months, insiders sold 0 shares of Taysha Gene Therapies Inc (TSHA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 582,095 shares of Taysha Gene Therapies Inc (TSHA) were sold and 19,238,333 shares were bought by its insiders, resulting in a net purchase of 18,656,238 shares.
Taysha Gene Therapies Inc (TSHA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Taysha Gene Therapies Inc Insider Transactions
Audentes Therapeutics, Inc. Mailing Address
Above is the net worth, insider trading, and ownership report for Audentes Therapeutics, Inc.. You might contact Audentes Therapeutics, Inc. via mailing address: 600 California St., 17th Floor, San Francisco Ca 94108.